Lower Mainland - Reference Ranges
Reference intervals are validated and updated periodically, and vary from method to method. They may change without notification. Ranges accompanying patient results should be deemed to be correct.
Revision date: January 31, 2003
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z | ||||||
|
Test |
Gender |
Patient Age |
Ref Interval |
SI Units |
||
|
1,25 DIHYDROXYVITAMIN D (1,25(OH)2 VIT D) |
M/F |
<100 Y |
40--120 |
pmol/L |
||
|
17OH PROGESTERONE |
M/F |
<12 Y |
0--3.0 |
nmol/L |
||
|
17OH PROGESTERONE |
F |
Follicular |
0.3--3.6 |
nmol/L |
||
|
17OH PROGESTERONE |
F |
Luteal |
0.9--14.4 |
nmol/L |
||
|
17OH PROGESTERONE |
F |
Post Menopausal |
0.3--1.8 |
nmol/L |
||
|
17OH PROGESTERONE |
M |
<100 Y |
1.2--11.9 |
nmol/L |
||
|
25 HYDROXYVITAMIN D (25(OH) VIT D) |
M/F |
<100 Y |
25--100 |
nmol/L |
||
|
ACE |
M/F |
<100 Y |
10--52 |
U/L |
||
|
ACTH |
M/F |
<100 Y |
<15 |
pmol/L |
||
|
AFP |
M/F |
<100Y |
<11 |
ug/L |
||
|
ALBUMIN |
M/F |
<100 Y |
35.0--50.0 |
g/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M/F |
=<3 Y |
110--320 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M/F |
4-6 Y |
150--380 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M/F |
7-9 Y |
175--420 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
F |
10-11 Y |
130--560 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
F |
12-13 Y |
105--420 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
F |
14-15 Y |
70--230 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
F |
16-19 Y |
50--130 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M |
10-11 Y |
135--530 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M |
12-13 Y |
200--495 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M |
14-15 Y |
130--525 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M |
16-19 Y |
65--260 |
U/L |
||
|
ALKALINE PHOSPHATASE (ALK PHOSPHATASE) |
M/F |
20-100 Y |
40--120 |
U/L |
||
|
ALPHA 1 ANTITRYPSIN (A1 ANTITRYPSIN) |
M/F |
<100 Y |
0.80--2.00 |
g/L |
||
|
ALT |
M/F |
0-12 M |
6--50 |
U/L |
||
|
ALT |
M/F |
1-3 Y |
5--45 |
U/L |
||
|
ALT |
M/F |
4-6 Y |
10--25 |
U/L |
||
|
ALT |
M/F |
7-9Y |
10--35 |
U/L |
||
|
ALT |
F |
10-13 Y |
10--30 |
U/L |
||
|
ALT |
F |
14-15 Y |
5--30 |
U/L |
||
|
ALT |
F |
16-19 Y |
5--35 |
U/L |
||
|
ALT |
F |
>19 Y |
10--55 |
U/L |
||
|
ALT |
M |
10-11 Y |
10--35 |
U/L |
||
|
ALT |
M |
12-13 Y |
10--55 |
U/L |
||
|
ALT |
M |
14-15 Y |
10--45 |
U/L |
||
|
ALT |
M |
16-19 Y |
10--40 |
U/L |
||
|
ALT |
M |
20-29 Y |
20--55 |
U/L |
||
|
ALT |
M |
>29 Y |
20--65 |
U/L |
||
|
AMYLASE |
M/F |
<100 Y |
30--110 |
U/L |
||
|
ANA |
M/F |
<100 Y |
Negative |
|||
|
ANDROSTENEDIONE |
M/F |
<11 Y |
<1.4 |
nmol/L |
||
|
ANDROSTENEDIONE |
M/F |
=>11 Y |
1.4--9.8 |
nmol/L |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGG) |
M/F |
<100 Y |
>80 High Positive |
GPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGG) |
M/F |
<100 Y |
0--15.0 Negative |
GPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGG) |
M/F |
<100 Y |
16--20 Indeterminate |
GPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGG) |
M/F |
<100 Y |
21-80 Low to Moderate Positive |
GPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGM) |
M/F |
<100 Y |
21-80 Low to Moderate Positive |
MPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGM) |
M/F |
<100 Y |
>80 High Positive |
MPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGM) |
M/F |
<100 Y |
0--12 Negative |
MPL Units |
||
|
ANTI CARDIOLIPIN ANTIBODY (CARDIOLIPIN AB IGM) |
M/F |
<100 Y |
13-20 Indeterminate |
MPL Units |
||
|
ANTI DNA ANTIBODY (DNA AB) |
M/F |
<100 Y |
0--4 |
kU/L |
||
|
ANTI MITOCHONDRIAL ANTIBODY (MITOCHONDRIAL AB) |
M/F |
<100 Y |
Titre <1:20 |
|||
|
ANTI MITOCHONDRIAL ANTIBODY (MITOCHONDRIAL AB) |
M/F |
<100 Y |
Negative |
|||
|
ANTI PARIETAL CELL ANTIBODY (PARIETAL CELL AB) |
M/F |
<100 Y |
Negative |
|||
|
ANTI PARIETAL CELL ANTIBODY (PARIETAL CELL AB) |
M/F |
<100 Y |
Titre <1:20 |
|||
|
ANTI SMOOTH MUSCLE ANTIBODY (SMOOTH MUSCLE AB) |
M/F |
<100 Y |
Negative |
|||
|
ANTI SMOOTH MUSCLE ANTIBODY (SMOOTH MUSCLE AB) |
M/F |
<100 Y |
Titre <1:20 |
|||
|
ANTITHROMBIN |
M/F |
<100 Y |
>0.85 |
Units |
||
|
ANTI THYROID ANTIBODIES (MICROSOMAL AB) |
M/F |
<100 Y |
Negative |
|||
|
ANTI TISSUE TRANSGLUTAMINASE IgA (TTG ANTIBODY IGA) |
M/F |
<100 Y |
<20 |
Units |
||
|
APOLIPOPROTEIN A-1 (APOLIPO A-1) |
M |
<100 Y |
0.95--1.80 |
g/L |
||
|
APOLIPOPROTEIN A-1 (APOLIPO A-1) |
F |
<100 Y |
1.00--2.00 |
g/L |
||
|
APOLIPOPROTEIN B-100 (APOLIPO B-100) |
M |
<100 Y |
0.53--1.27 |
g/L |
||
|
APOLIPOPROTEIN B-100 (APOLIPO B-100) |
F |
<100 Y |
0.49--1.03 |
g/L |
||
|
AST |
M/F |
<6 D |
35--140 |
U/L |
||
|
AST |
M/F |
6 D--1 Y |
20--60 |
U/L |
||
|
AST |
M/F |
2-3 Y |
20--60 |
U/L |
||
|
AST |
M/F |
4-6 Y |
15--50 |
U/L |
||
|
AST |
M/F |
7-9 Y |
15--40 |
U/L |
||
|
AST |
F |
10-11 Y |
10--40 |
U/L |
||
|
AST |
F |
12-15 Y |
10--30 |
U/L |
||
|
AST |
F |
16-19 Y |
5--30 |
U/L |
||
|
AST |
F |
20-29 Y |
10--35 |
U/L |
||
|
AST |
F |
>29 Y |
10--40 |
U/L |
||
|
AST |
M |
10-11Y |
10--60 |
U/L |
||
|
AST |
M |
12-15 Y |
15--40 |
U/L |
||
|
AST |
M |
16-19 Y |
15--45 |
U/L |
||
|
AST |
M |
20-29 Y |
15--35 |
U/L |
||
|
AST |
M |
>29 Y |
15--45 |
U/L |
||
|
B2 MICROGLOBULIN (BETA 2 MICROGLOB) |
M/F |
=<60 Y |
0--204 |
nmol/L |
||
|
B2 MICROGLOBULIN (BETA 2 MICROGLOB) |
M/F |
61-100 Y |
0--254 |
nmol/L |
||
|
BETA hCG (hCG BETA) |
F |
Non pregnant |
<5 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 0-1 W |
5--50 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 1-2 W |
40--300 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 2-3 W |
100--1,000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 3-4 W |
500--6000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 1-2 M |
5000--200,000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
Pregnant 2-3 M |
10,000--100,000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
2nd Trimester |
3000--50,000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
F |
3rd Trimester |
1,000--50,000 |
IU/L |
||
|
BETA hCG (hCG BETA) |
M |
<100 Y |
<5 |
IU/L |
||
|
BICARBONATE |
M/F |
<100 Y |
20--29 |
mmol/L |
||
|
BILIRUBIN DIRECT (BILIRUBIN CONJ) |
M/F |
=<14 D |
2--30 |
umol/L |
||
|
BILIRUBIN DIRECT (BILIRUBIN CONJ) |
M/F |
15 D-100 Y |
0--8 |
umol/L |
||
|
BILIRUBIN TOTAL |
M/F |
15 D-100 Y |
0--20 |
umol/L |
||
|
BLOOD CADMIUM NONSMOKER (CADMIUM) |
M/F |
<100 Y |
2.7--10.7 |
nmol/L |
||
|
BLOOD CADMIUM SMOKER (CADMIUM) |
M/F |
<100 Y |
5.3--34.7 |
nmol/L |
||
|
BLOOD LEAD (LEAD BLOOD) |
M/F |
<100 Y |
0--1.93 |
umol/L |
||
|
BLOOD MERCURY (MERCURY RBC) |
M/F |
<100 Y |
0--49 |
nmol/L |
||
|
C REACTIVE PROTEIN |
M/F |
<100 Y |
<5.0 |
mg/L |
||
|
CA 125 |
M/F |
<100 Y |
<35 |
KU/L |
||
|
CA 15-3 |
M/F |
<100 Y |
0--25 |
KU/L |
||
|
CALCIUM |
M/F |
<100 Y |
2.15--2.50 |
mmol/L |
||
|
CARBAMAZEPINE |
M/F |
<100 Y |
17--51 Therapeutic |
umol/L |
||
|
CAROTENE |
M/F |
<100 Y |
0.9--4.7 |
umol/L |
||
|
CERULOPLASMIN |
M/F |
=<42 D |
0.14--0.41 |
g/L |
||
|
CERULOPLASMIN |
M/F |
43 D-100 Y |
0.15--0.60 |
g/L |
||
|
CHLORIDE |
M/F |
<100 Y |
98--106 |
mmol/L |
||
|
CHOLESTEROL |
M/F |
>=30 Y |
2.00--5.19 |
mmol/L |
||
|
CHOLESTEROL |
M/F |
19-29 Y |
2.00--4.59 |
mmol/L |
||
|
CHOLESTEROL |
M/F |
<=18 Y |
2.00--4.39 |
mmol/L |
||
|
CK ISOENZYME (CKMB ISO) |
M/F |
<100 Y |
0--6 |
|||
|
CK ISOENZYME (MB INDEX) |
M/F |
<100 Y |
0--0.030 |
|||
|
COLD AGGLUTININS (COLD AGGLUTININ TITRE) |
M/F |
<100 Y |
Titre <1:64 |
|||
|
COLD AGGLUTININS |
M/F |
<100 Y |
Negative |
|||
|
COMPLEMENT C3 (COMPLEMENT 3) |
M/F |
<100 Y |
0.9--1.80 |
g/L |
||
|
COMPLEMENT C4 (COMPLEMENT 4) |
M/F |
<100 Y |
0.1--0.4 |
g/L |
||
|
COPPER SERUM (COPPER) |
M |
<100 Y |
11--22 |
umol/L |
||
|
COPPER SERUM (COPPER) |
F |
<100 Y |
13--24 |
umol/L |
||
|
CORTISOL AM |
M/F |
<100 Y |
140--690 |
nmol/L |
||
|
CORTISOL AM FOLLOWING DEXAMETHASONE (CORTISOL am) |
M/F |
<100 Y |
<140 |
nmol/L |
||
|
CORTISOL PM |
M/F |
<100 Y |
50--300 |
nmol/L |
||
|
CREATINE KINASE |
F |
<100 Y |
<185 |
U/L |
||
|
CREATINE KINASE |
M |
<100 Y |
<220 |
U/L |
||
|
CREATININE |
M/F |
=<5 Y |
10--50 |
umol/L |
||
|
CREATININE |
M/F |
6-10 Y |
30--80 |
umol/L |
||
|
CREATININE |
M/F |
11-18 Y |
35--100 |
umol/L |
||
|
CREATININE |
M |
19-100 Y |
70--120 |
umol/L |
||
|
CREATININE |
F |
19-100 Y |
50--100 |
umol/L |
||
|
CREATININE CLEARANCE 12H (CORRECTED CLR 12h) |
F |
=<50 Y |
1.14--2.24 |
mL/s |
||
|
CREATININE CLEARANCE 12H (CORRECTED CLR 12h) |
M |
=<50 Y |
1.25--2.44 |
mL/s |
||
|
CREATININE CLEARANCE 12H (CORRECTED CLR 12h) |
F |
51-100 Y |
0.87--1.94 |
mL/s |
||
|
CREATININE CLEARANCE 12H (CORRECTED CLR 12h) |
M |
51-100 Y |
0.92--2.10 |
mL/s |
||
|
CREATININE CLEARANCE 24H (CORRECTED CLR 24h) |
F |
=<50 Y |
1.14--2.24 |
mL/s |
||
|
CREATININE CLEARANCE 24H (CORRECTED CLR 24h) |
M |
=<50 Y |
1.25--2.44 |
mL/s |
||
|
CREATININE CLEARANCE 24H (CORRECTED CLR 24h) |
F |
51-100 Y |
0.87--1.94 |
mL/s |
||
|
CREATININE CLEARANCE 24H (CORRECTED CLR 24h) |
M |
51-100 Y |
0.92--2.10 |
mL/s |
||
|
CRYOFIBRINOGEN |
M/F |
<100 Y |
0.00--0.04 |
|||
|
CRYOGLOBULIN |
M/F |
<100 Y |
0.00--0.04 |
|||
|
DHEAS (DHEA-S) |
F |
Prepubertal |
<2.6 |
umol/L |
||
|
DHEAS (DHEA-S) |
F |
Adult |
0.7--11.7 |
umol/L |
||
|
DHEAS (DHEA-S) |
F |
Post Menopausal |
0.7--6.5 |
umol/L |
||
|
DHEAS (DHEA-S) |
M |
Prepubertal |
<2.0 |
umol/L |
||
|
DHEAS (DHEA-S) |
M |
Adult |
5.2--14.2 |
umol/L |
||
|
DHEAS (DHEA-S) |
M |
>50 Y |
1.3--8.4 |
umol/L |
||
|
DIGOXIN |
M/F |
<100 Y |
1.0--2.6 Therapeutic |
nmol/L |
||
|
DIRECT COOMBS (DIRECT ANTIGLOBULIN TEST) |
--- |
--- |
No range |
|||
|
DRVV |
M/F |
29--42 |
s |
|||
|
ENA (RNP) |
M/F |
<100 Y |
Negative |
|||
|
ENA (Scl-70) |
M/F |
<100 Y |
Negative |
|||
|
ENA (Sm) |
M/F |
<100 Y |
Negative |
|||
|
ENA (SS-A) |
M/F |
<100 Y |
Negative |
|||
|
ENA (SS-B) |
M/F |
<100 Y |
Negative |
|||
|
ESTRADIOL |
F |
Follicular |
110--184 |
pmol/L |
||
|
ESTRADIOL |
F |
Ovulatory Peak |
550--1650 |
pmol/L |
||
|
ESTRADIOL |
F |
Luteal |
550--845 |
pmol/L |
||
|
ESTRADIOL |
F |
Post Menopausal |
<220 |
pmol/L |
||
|
ESTRADIOL |
M |
<100 Y |
0--220 |
pmol/L |
||
|
FERRITIN |
F |
<100 Y |
Normal: 10--160 |
ug/L |
||
|
FERRITIN |
F |
<100 Y |
<10 Iron deficient |
ug/L |
||
|
FERRITIN |
M |
<100 Y |
<20 Iron deficient |
ug/L |
||
|
FERRITIN |
M |
<100 Y |
Normal: 20--325 |
ug/L |
||
|
FIBRINOGEN |
M/F |
<100 Y |
1.7--4.10 |
g/L |
||
|
FLUORIDE |
M/F |
<100 Y |
0.0--22.8 Therapeutic |
umol/L |
||
|
FLUORIDE |
M/F |
<100 Y |
0.0--5.1 Reference range |
umol/L |
||
|
FOLIC ACID (FOLATE) |
M/F |
<100 Y |
>5.0 |
nmol/L |
||
|
FREE CALCIUM (CALCIUM IONIZED) |
M/F |
<100 Y |
1.15--1.35 |
mmol/L |
||
|
FREE CALCIUM (pH SERUM) |
M/F |
<100 Y |
7.33--7.45 |
|||
|
FREE T3 (T3 FREE) |
M/F |
<100 Y |
2.23--5.35 |
pmol/L |
||
|
FREE T4 (T4 FREE) |
M/F |
Child |
14.5--33.0 |
pmol/L |
||
|
FREE T4 (T4 FREE) |
M/F |
Adult |
10.5--20.0 |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
=<20 Y |
puberty dependant |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
21-30 Y |
24--95 |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
31-40 Y |
25--89 |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
41-50 Y |
23--82 |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
51-60 Y |
23--80 |
pmol/L |
||
|
FREE TESTOSTERONE |
M |
61-100 Y |
22--74 |
pmol/L |
||
|
FREE TESTOSTERONE |
F |
61-100 Y |
0.5--6.4 |
pmol/L |
||
|
FREE TESTOSTERONE |
F |
21-60 Y |
0.5--8.1 |
pmol/L |
||
|
FREE TESTOSTERONE |
F |
=<20 Y |
puberty dependant |
pmol/L |
||
|
FSH |
M/F |
Prepubertal |
1.3--4.5 |
IU/L |
||
|
FSH |
F |
Mid-Cycle |
5--22 |
IU/L |
||
|
FSH |
F |
Follicular |
2--13 |
IU/L |
||
|
FSH |
F |
Luteal |
2--13 |
IU/L |
||
|
FSH |
F |
Post Menopausal |
20--138 |
IU/L |
||
|
FSH |
M |
<100 Y |
1--8 |
IU/L |
||
|
GAMMA GT |
M/F |
<100 Y |
10--58 |
U/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 2H (GLUCOSE 1h) |
F |
<100 Y |
3.3--9.9 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 3H (GLUCOSE 1h) |
F |
<100 Y |
3.3--9.9 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 2H (GLUCOSE 2h) |
F |
<100 Y |
3.3--8.5 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 3H (GLUCOSE 2h) |
F |
<100 Y |
3.3--8.5 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 3H (GLUCOSE 3h) |
F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 2H (GLUCOSE FASTING) |
F |
<100 Y |
3.3--5.2 |
mmol/L |
||
|
GESTATIONAL GLUCOSE TOLERANCE 3H (GLUCOSE FASTING) |
F |
<100 Y |
3.3--5.2 |
mmol/L |
||
|
GESTATIONAL SCREEN FOR DIABETES (GLUCOSE 1h) |
F |
<100 Y |
4.4--7.7 |
mmol/L |
||
|
GLUCOSE |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE 2H PC |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE FASTING |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 0.5H (GLUCOSE 0.5h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 1.5H (GLUCOSE 1.5h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 3H (GLUCOSE 1h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 1H (GLUCOSE 1h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 1h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE 1h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 4H (GLUCOSE 1h) |
M/F |
<100 Y |
3.3--11.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 2h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE 2h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 4H (GLUCOSE 2h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 3H (GLUCOSE 2h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 2H (GLUCOSE 2h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 4H (GLUCOSE 3h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 3H (GLUCOSE 3h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE 3h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 3h) |
M/F |
<100 Y |
3.3--7.7 |
mmol/L |
||
|
GLUCOSE TOLERANCE 4H (GLUCOSE 4h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE 4h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 4h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE 5h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 5h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE 6h) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 6H (GLUCOSE FASTING) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 3H (GLUCOSE FASTING) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 5H (GLUCOSE FASTING) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 4H (GLUCOSE FASTING) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GLUCOSE TOLERANCE 2H (GLUCOSE FASTING) |
M/F |
<100 Y |
3.3--6.0 |
mmol/L |
||
|
GROWTH HORMONE (SOMATOTROPIN) |
M/F |
<100 Y |
<5 |
ug/L |
||
|
HAPTOGLOBIN |
M/F |
=<19.4 Y |
0.22--1.64 |
g/L |
||
|
HAPTOGLOBIN |
M/F |
19.5-100 Y |
0.30--2.00 |
g/L |
||
|
HDL CHOLESTEROL (CHOLESTEROL/HDL) |
F |
<100 Y |
<4.4 |
|||
|
HDL CHOLESTEROL (CHOLESTEROL/HDL) |
M |
<100 Y |
<4.9 |
|||
|
HDL CHOLESTEROL (HDL-CHOLESTEROL) |
M |
>19 Y |
>0.90 |
mmol/L |
||
|
HDL CHOLESTEROL (HDL-CHOLESTEROL) |
M/F |
<=18 Y |
>1.00 |
mmol/L |
||
|
HDL CHOLESTEROL (HDL-CHOLESTEROL) |
F |
>19 Y |
>1.10 |
mmol/L |
||
|
HDL CHOLESTEROL (LDL-CHOLESTEROL) |
M/F |
19-29 Y |
1.50--2.99 |
mmol/L |
||
|
HDL CHOLESTEROL (LDL-CHOLESTEROL) |
M/F |
<=18 Y |
1.50--2.79 |
mmol/L |
||
|
HDL CHOLESTEROL (LDL-CHOLESTEROL) |
M/F |
>=30 Y |
1.50--3.39 |
mmol/L |
||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
=<7 D |
0.41--0.73 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
8-29 D |
0.42--0.60 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
30-59 D |
0.39--0.63 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
2-5 M |
0.28--0.42 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
6-11 M |
0.29--0.41 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
1-4 Y |
0.33--0.39 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
5 Y |
0.34--0.40 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M/F |
6-11 Y |
0.35--0.43 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M |
12-15 Y |
0.37--0.47 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
F |
12-15 Y |
0.35--0.44 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M |
16-18 Y |
0.38--0.49 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
F |
16-18 Y |
0.35--0.44 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
M |
19-100 Y |
0.38--0.50 |
|||
|
HEMATOLOGY PANEL (HEMATOCRIT) |
F |
19-100 Y |
0.35--0.43 |
|||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
=<7 D |
150--250 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
8-29 D |
149--229 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
30-59 D |
102--182 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
2-5 M |
91--131 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
6-11 M |
101--129 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
1-4 Y |
107--131 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
5 Y |
107--147 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M/F |
6-11 Y |
118--146 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
F |
12-18 Y |
117--149 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
F |
19-100 Y |
120--150 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M |
12-15 Y |
125--165 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M |
16-18 Y |
131--169 |
g/L |
||
|
HEMATOLOGY PANEL (HEMOGLOBIN) |
M |
19-100 Y |
133--165 |
g/L |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
=<29 D |
31.0--37.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
30-59 D |
29.0--36.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
2-5 M |
26.0--34.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
6-11 M |
25.0--35.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
1-4 Y |
23.0--31.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
5 Y |
24.0--30.0 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
6-15 Y |
25.8--31.7 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
16-18 Y |
25.0--33.8 |
pg |
||
|
HEMATOLOGY PANEL (MCH) |
M/F |
19-100 Y |
27.5--33.5 |
pg |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
=<7 D |
300--366 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
8-29 D |
300--366 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
30-59 D |
280--360 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
2-5 M |
290--370 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
6-11 M |
290--360 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
1-4 Y |
300--360 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
5 Y |
310--370 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M/F |
6-11 Y |
330--351 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M |
12-15 Y |
330--351 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
F |
12-15 Y |
330--351 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M |
16-18 Y |
330--355 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
F |
16-18 Y |
330--355 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
M |
19-100 Y |
320--360 |
g/L |
||
|
HEMATOLOGY PANEL (MCHC) |
F |
19-100 Y |
320--360 |
g/L |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
=<7 D |
95--121 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
8-29 D |
88--126 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
30-59 D |
86--124 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
2-5 M |
77--105 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
6 M-4 Y |
73-86 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
5 Y |
75--87 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M/F |
6-11 Y |
77--92 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M |
12-15 Y |
77--92 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
F |
12-15 Y |
77--92 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M |
16-18 Y |
80--95 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
F |
16-18 Y |
80--95 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
M |
19-100 Y |
82--98 |
fl |
||
|
HEMATOLOGY PANEL (MCV) |
F |
19-100 Y |
82--98 |
fl |
||
|
HEMATOLOGY PANEL (PLATELET COUNT) |
M/F |
<100 Y |
150--400 |
giga/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
=<7 D |
4.00--6.60 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
8-29 D |
3.90--6.30 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
30-59 D |
3.30--5.30 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
2-5 M |
2.70--4.90 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
6-11 M |
3.10--4.50 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
1-4 Y |
3.70--5.30 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
5 Y |
3.90--5.30 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M/F |
6-11 Y |
4.05--5.15 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M |
12-15 Y |
4.43--5.53 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
F |
12-15 Y |
4.05--4.98 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M |
16-18 Y |
4.41--5.71 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
F |
16-18 Y |
4.00--4.87 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
M |
19-100 Y |
4.20--5.40 |
tera/L |
||
|
HEMATOLOGY PANEL (RBC) |
F |
19-100 Y |
3.80--4.80 |
tera/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
=<7 D |
9.0--30.0 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
8-29 D |
5.0--20.0 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
30-59 D |
5.0--19.5 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
2-5 M |
5.5--18.0 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
6-11 M |
5.0--15.0 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
1-4 Y |
5.0--12.0 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
5-18 Y |
3.9--10.2 |
giga/L |
||
|
HEMATOLOGY PANEL (WBC) |
M/F |
19-100 Y |
4.0--10.0 |
giga/L |
||
|
HEMOGLOBIN |
M/F |
=<7 D |
150--250 |
g/L |
||
|
HEMOGLOBIN |
M/F |
8-29 D |
149--229 |
g/L |
||
|
HEMOGLOBIN |
M/F |
30-59 D |
102--182 |
g/L |
||
|
HEMOGLOBIN |
M/F |
2-5 M |
91--131 |
g/L |
||
|
HEMOGLOBIN |
M/F |
6-11 M |
101--129 |
g/L |
||
|
HEMOGLOBIN |
M/F |
1-4 Y |
107--131 |
g/L |
||
|
HEMOGLOBIN |
M/F |
5 Y |
107--147 |
g/L |
||
|
HEMOGLOBIN |
M/F |
6-11 Y |
118--146 |
g/L |
||
|
HEMOGLOBIN |
F |
12-18 Y |
117--149 |
g/L |
||
|
HEMOGLOBIN |
F |
19-100 Y |
120--150 |
g/L |
||
|
HEMOGLOBIN |
M |
12-15 Y |
125--165 |
g/L |
||
|
HEMOGLOBIN |
M |
16-18 Y |
131--169 |
g/L |
||
|
HEMOGLOBIN |
M |
19-100 Y |
133--165 |
g/L |
||
|
HEMOGLOBIN A1C |
M/F |
<100 Y |
0.043--0.060 |
|||
|
HEMOGLOBIN A1C & RATIO (HEMOGLOBIN A1C) |
M/F |
<100 Y |
0.043--0.060 |
|||
|
HEMOGLOBIN A2 |
M/F |
<100 Y |
1.0--3.5 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS (HEMOGLOBIN A2) |
M/F |
<100 Y |
1.0--3.5 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
0-29 D |
60--95 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
30-59 D |
35--86 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
2-4 M |
11--56 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
4-5 M |
3--14 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
6-12 M |
1--4 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
13-18 M |
0.5--2.9 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
19-24 M |
0.2--2.6 |
% |
||
|
HEMOGLOBIN ELECTROPHORESIS & DIFF (HEMOGLOBIN F) |
M/F |
25 M -100 Y |
<2.0 |
% |
||
|
HEPATITIS B CORE ANTIBODY (HEP B CORE AB) |
M/F |
<100 Y |
Negative |
|||
|
HEPATITIS B SURFACE ANTIBODY (HEP B SURFACE AB) |
M/F |
<100 Y |
>10.0 Pos/Immune |
IU/L |
||
|
HEPATITIS B SURFACE ANTIBODY (HEP B SURFACE AB) |
M/F |
<100 Y |
0--5.0 Neg/Non-immune |
IU/L |
||
|
HEPATITIS B SURFACE ANTIBODY (HEP B SURFACE AB) |
M/F |
<100 Y |
5.1--10.0 Borderline |
IU/L |
||
|
HEPATITIS B SURFACE AG (HEP B SURFACE AG) |
M/F |
<100 Y |
Negative |
|||
|
HLA B27 (HLA-B27) |
M/F |
<100Y |
Negative |
|||
|
HOMOCYSTEINE |
M |
>12 Y |
<9.2 |
umol/L |
||
|
HOMOCYSTEINE |
M |
<=12 Y |
not available |
umol/L |
||
|
HOMOCYSTEINE |
F |
>12 Y |
<7.8 |
umol/L |
||
|
HOMOCYSTEINE |
F |
<=12 Y |
not available |
umol/L |
||
|
IGE |
M/F |
=<2 Y |
0--120 |
ug/L |
||
|
IGE |
M/F |
3-11 Y |
0--240 |
ug/L |
||
|
IGE |
M/F |
12-14 Y |
0--290 |
ug/L |
||
|
IGE |
M/F |
Adult |
0--430 |
ug/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
=<1 Y |
0.00--1.00 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
2-3 Y |
0.24--1.92 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
4-6 Y |
0.26--2.32 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
7-9 Y |
0.33--2.58 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
10-15 Y |
0.45--3.17 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
16-17 Y |
0.55--3.77 |
g/L |
||
|
IMMUNOGLOBULINS (IgA) |
M/F |
18-100 Y |
0.7--4.0 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
=<3 M |
2.73--16.6 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
4-6 M |
3.73--14.6 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
7-9 M |
4.73--12.6 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
10 M-3 Y |
4.00--12.5 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
4-6 Y |
5.60--13.07 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
7-9 Y |
6.00--13.8 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
10-15 Y |
6.38--15.31 |
g/L |
||
|
IMMUNOGLOBULINS (IgG) |
M/F |
16-100 Y |
7.00--16.00 |
g/L |
||
|
IMMUNOGLOBULINS (IgM) |
M/F |
=<2 M |
0.12--1.25 |
g/L |
||
|
IMMUNOGLOBULINS (IgM) |
M/F |
3 M-4 Y |
0.21--1.63 |
g/L |
||
|
IMMUNOGLOBULINS (IgM) |
M/F |
5-19 Y |
0.40--2.26 |
g/L |
||
|
IMMUNOGLOBULINS (IgM) |
M/F |
20-100 Y |
0.40--2.30 |
g/L |
||
|
IRON |
M/F |
<100 Y |
10--33 |
umol/L |
||
|
JOINT FLUID ANA (ANA) |
M/F |
<100 Y |
Negative |
|||
|
JOINT FLUID DIFF (LYMPHOCYTES) |
M/F |
<100 Y |
0--78 |
% |
||
|
JOINT FLUID DIFF (MONONUCLEAR) |
M//F |
<100 Y |
0--65 |
% |
||
|
JOINT FLUID DIFF (NEUTROPHILS) |
M/F |
<100 Y |
0--25 |
% |
||
|
JOINT FLUID DIFF (WBC) |
M/F |
<100 Y |
13--180 |
mega/L |
||
|
JOINT FLUID GLUCOSE (GLUCOSE JF) |
M/F |
<100 Y |
3.3--6.7 |
mmol/L |
||
|
JOINT FLUID PROTEIN (PROTEIN JF) |
M/F |
<100 Y |
10--30 |
g/L |
||
|
JOINT FLUID URIC ACID (URATE JF) |
M |
<100 Y |
190--404 |
umol/L |
||
|
JOINT FLUID URIC ACID (URATE JF) |
F |
<100 Y |
107--309 |
umol/L |
||
|
KETONES BLOOD (KETONES) |
M/F |
<100 Y |
Negative |
|||
|
LDH (LD) |
M/F |
0-5 D |
934--2150 |
U/L |
||
|
LDH (LD) |
M/F |
6-30 D |
550--2100 |
U/L |
||
|
LDH (LD) |
M/F |
1-12 M |
380--1230 |
U/L |
||
|
LDH (LD) |
M/F |
1-3 Y |
500--920 |
U/L |
||
|
LDH (LD) |
M/F |
4-6 Y |
470--900 |
U/L |
||
|
LDH (LD) |
M/F |
7-9 Y |
420--750 |
U/L |
||
|
LDH (LD) |
F |
10-11 Y |
380--770 |
U/L |
||
|
LDH (LD) |
F |
12-13 Y |
380--640 |
U/L |
||
|
LDH (LD) |
F |
14-15 Y |
390--580 |
U/L |
||
|
LDH (LD) |
M |
10-11 Y |
432--700 |
U/L |
||
|
LDH (LD) |
M |
12-13 Y |
470--750 |
U/L |
||
|
LDH (LD) |
M |
14-15 Y |
360--730 |
U/L |
||
|
LDH (LD) |
M/F |
16-19 Y |
340--670 |
U/L |
||
|
LDH (LD) |
M/F |
>19 Y |
300--600 |
U/L |
||
|
LDH ISOENZYMES (LD ISO 1) |
M/F |
<100 Y |
0.17--0.31 |
|||
|
LDH ISOENZYMES (LD ISO 2) |
M/F |
<100 Y |
0.35--0.48 |
|||
|
LDH ISOENZYMES (LD ISO 3) |
M/F |
<100 Y |
0.15--0.29 |
|||
|
LDH ISOENZYMES (LD ISO 4) |
M/F |
<100 Y |
0.04--0.09 |
|||
|
LDH ISOENZYMES (LD ISO 5) |
M/F |
<100 Y |
0.03--0.10 |
|||
|
LH |
F |
Follicular |
1--20 |
IU/L |
||
|
LH |
F |
Ovulatory Peak |
24--105 |
IU/L |
||
|
LH |
F |
Luteal |
1--20 |
IU/L |
||
|
LH |
F |
Post Menopausal |
15--62 |
IU/L |
||
|
LH |
M |
<100 Y |
2--12 |
IU/L |
||
|
LH FOR FERTILITY (LH (FERTILITY)) |
F |
Adult |
1.0--105 |
IU/L |
||
|
LIPASE |
M/F |
<100 Y |
23--300 |
U/L |
||
|
LITHIUM |
M/F |
<=64 Y |
0.5--1.5 |
mmol/L |
||
|
LITHIUM |
M/F |
>=65 Y |
0.5--1.2 |
mmol/L |
||
|
MACROPROLACTIN |
F |
<100 Y |
0.50--1.00 |
recovery |
||
|
MAGNESIUM |
M/F |
<100 Y |
0.65--0.95 |
mmol/L |
||
|
NEONATAL BILIRUBIN (BILIRUBIN CONJ) |
M/F |
=<14 D |
2--30 |
umol/L |
||
|
NEONATAL BILIRUBIN (BILIRUBIN CONJ) |
M/F |
15 D-100 Y |
0--8 |
umol/L |
||
|
NEONATAL BILIRUBIN (BILIRUBIN UNCONJ) |
M/F |
=<5 D |
2--260 |
umol/L |
||
|
NEONATAL BILIRUBIN (BILIRUBIN UNCONJ) |
M/F |
6-14 D |
2--170 |
umol/L |
||
|
OSMOLALITY |
M/F |
=<60 Y |
270--295 |
mosmol/kg |
||
|
OSMOLALITY |
M/F |
>60 Y |
280--300 |
mosmol/kg |
||
|
OSTEOCALCIN |
F |
<100 Y |
0.46--1.95 |
nmol/L |
||
|
OSTEOCALCIN |
M |
<100 Y |
0.54--2.07 |
nmol/L |
||
|
PARATHYROID HORMONE (PTH) |
M/F |
<100 Y |
1.0--5.5 |
pmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
=<1 M |
1.71--3.16 |
mmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
2 M-1 Y |
1.36--2.29 |
mmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
2-5 Y |
1.23--2.20 |
mmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
6-10 Y |
1.16--2.00 |
mmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
11-20 Y |
0.94--1.78 |
mmol/L |
||
|
PEI/TRP (PHOSPHORUS) |
M/F |
21-100 Y |
0.80--1.40 |
mmol/L |
||
|
PHENOBARBITAL |
M/F |
=<10 Y |
43--172 |
umol/L |
||
|
PHENOBARBITAL |
M/F |
11-100 Y |
65--172 |
umol/L |
||
|
PHENYTOIN |
M/F |
=<3 M |
24--55 Therapeutic |
umol/L |
||
|
PHENYTOIN |
M/F |
4 M-100 Y |
40--80 |
umol/L |
||
|
PHOSPHORUS |
M/F |
=<1 M |
1.71--3.16 |
mmol/L |
||
|
PHOSPHORUS |
M/F |
2 M-1 Y |
1.36--2.29 |
mmol/L |
||
|
PHOSPHORUS |
M/F |
2-5 Y |
1.23--2.20 |
mmol/L |
||
|
PHOSPHORUS |
M/F |
6-10 Y |
1.16--2.00 |
mmol/L |
||
|
PHOSPHORUS |
M/F |
11-20 Y |
0.94--1.78 |
mmol/L |
||
|
PHOSPHORUS |
M/F |
21-100 Y |
0.80--1.40 |
mmol/L |
||
|
PLATELET COUNT |
M/F |
<100 Y |
150--400 |
giga/L |
||
|
POTASSIUM |
M/F |
<100 Y |
3.5--5.0 |
mmol/L |
||
|
PREGNANCY TEST (SPECIFIC GRAVITY) |
M/F |
<100 Y |
1.005--1.035 |
|||
|
PRIMIDONE |
M/F |
<100 Y |
25--55 |
umol/L |
||
|
PROGESTERONE |
F |
Follicular |
<5 |
nmol/L |
||
|
PROGESTERONE |
F |
Luteal |
8--90 |
nmol/L |
||
|
PROGESTERONE |
F |
Mid Luteal |
18--90 |
nmol/L |
||
|
PROGESTERONE |
F |
Post Meno/Oral Contraceptives |
<5 |
nmol/L |
||
|
PROGESTERONE |
M |
<100 Y |
<5 |
nmol/L |
||
|
PROLACTIN |
M |
<100 Y |
2.0--16.0 |
ug/L |
||
|
PROLACTIN |
F |
<100 Y |
2.0--25.0 |
ug/L |
||
|
PROTEIN |
M/F |
<100 Y |
60--80 |
g/L |
||
|
PROTEIN C |
M/F |
<100 Y |
>0.65 |
Units |
||
|
PROTEIN ELECTROPHORESIS (ALBUMIN) |
M/F |
<100 Y |
37--55 |
g/L |
||
|
PROTEIN ELECTROPHORESIS (ALPHA-1 GLOBULIN) |
M/F |
<100 Y |
1--3 |
g/L |
||
|
PROTEIN ELECTROPHORESIS (ALPHA-2 GLOBULIN) |
M/F |
<100 Y |
5--9 |
g/L |
||
|
PROTEIN ELECTROPHORESIS (BETA GLOBULIN) |
M/F |
<100 Y |
5--10 |
g/L |
||
|
PROTEIN ELECTROPHORESIS (GAMMA GLOBULIN) |
M/F |
<100 Y |
4.2--12.5 |
g/L |
||
|
PROTEIN ELECTROPHORESIS (PROTEIN) |
M/F |
<100 Y |
60--80 |
g/L |
||
|
PROTEIN S |
F |
<100 Y |
>0.7 |
Units |
||
|
PROTEIN S |
M |
<100 Y |
>0.8 |
Units |
||
|
PROTHROMBIN TIME (INR) |
M/F |
<100 Y |
0.8--1.2 |
|||
|
PSA |
M |
<50 Y |
0.0--2.5 |
ug/L |
||
|
PSA |
M |
50-59Y |
0.0--3.5 |
ug/L |
||
|
PSA |
M |
60-69Y |
0.0--4.5 |
ug/L |
||
|
PSA |
M |
>=70 Y |
0.0--6.5 |
ug/L |
||
|
PTT (PTT ACTIVATED) |
M/F |
<100 Y |
25--36 |
s |
||
|
RBC FOLATE (FOLATE RBC) |
M/F |
<100 Y |
>396 |
nmol/L |
||
|
RBC MAGNESIUM |
M/F |
<100 Y |
1.40--2.10 |
mmol/L |
||
|
RETICULOCYTE COUNT |
M/F |
<100 Y |
35--120 |
giga/L |
||
|
RHEUMATOID FACTOR (RHEUMATOID AB) |
M/F |
<100 Y |
<14 Negative |
kU/L |
||
|
RHEUMATOID FACTOR (RHEUMATOID AB) |
M/F |
<100 Y |
14--30 Indeterminate |
kU/L |
||
|
RHEUMATOID FACTOR (RHEUMATOID AB) |
M/F |
<100 Y |
>30 Positive |
kU/L |
||
|
SEDIMENTATION RATE (ESR) |
M |
<100 Y |
0--10 |
mm/h |
||
|
SEDIMENTATION RATE (ESR) |
F |
<100 Y |
0--20 |
mm/h |
||
|
SEMEN ANALYSIS (ABNORMAL FORMS) |
M |
<100 Y |
<=86 |
% |
||
|
SEMEN ANALYSIS (HRS OLD) |
M |
<100 Y |
0--2 |
h |
||
|
SEMEN ANALYSIS (IMMATURE FORMS) |
M |
<100 Y |
<3 |
/100 SPERM |
||
|
SEMEN ANALYSIS (MOTILITY) |
M |
=>50 |
% |
|||
|
SEMEN ANALYSIS (NORMAL FORMS) |
M |
<100 Y |
=>14 |
% |
||
|
SEMEN ANALYSIS (SPERM) |
M |
=>20 |
giga/L |
|||
|
SEMEN ANALYSIS (VIABILITY) |
M |
=>50 |
% |
|||
|
SEMEN ANALYSIS (VOLUME) |
M |
=>2 |
mL |
|||
|
SODIUM |
M/F |
<100 Y |
134--145 |
mmol/L |
||
|
SPECIFIC ALLERGEN IgE |
M/F |
<100 Y |
<0.35 |
KU/L |
||
|
STOOL MEAT FIBRES (MEAT FIBRES STOOL) |
M/F |
<100 Y |
0--10 |
/LPF |
||
|
STOOL pH (pH STOOL) |
M/F |
<100 Y |
5.0--9.0 |
|||
|
T3 TOTAL |
M/F |
<100 Y |
0.70--2.10 |
nmol/L |
||
|
T4 |
M/F |
4-21 D |
100--250 |
nmol/L |
||
|
T4 |
M/F |
21-60 D |
90--200 |
nmol/L |
||
|
T4 |
M/F |
60 D-1 Y |
65--180 |
nmol/L |
||
|
T4 |
M/F |
>1Y |
60--140 |
nmol/L |
||
|
TESTOSTERONE |
M |
<100 Y |
10.0--30.0 |
nmol/L |
||
|
TESTOSTERONE |
F |
<100 Y |
<4.5 |
nmol/L |
||
|
THEOPHYLLINE |
M/F |
<100 Y |
55--110 Therapeutic |
umol/L |
||
|
THYROGLOBULIN |
M/F |
<100 Y |
0--60 |
ug/L |
||
|
THYROGLOBULIN ANTIBODIES (THYROGLOBULIN AB) |
M/F |
<100 Y |
Negative |
|||
|
TRANSFERRIN |
M/F |
=<3.4 M |
0.99--2.31 |
g/L |
||
|
TRANSFERRIN |
M/F |
3.5 M-11.4 M |
0.94--3.77 |
g/L |
||
|
TRANSFERRIN |
M/F |
11.5 M-19.4 Y |
1.03--3.63 |
g/L |
||
|
TRANSFERRIN |
M/F |
19.5-100 Y |
2.00--3.60 |
g/L |
||
|
TRANSFERRIN SATURATION |
F |
<100 Y |
0.15--0.50 |
|||
|
TRANSFERRIN SATURATION |
M |
<100 Y |
0.20--0.50 |
|||
|
TRIGLYCERIDE |
M/F |
>=19 Y |
0.45--2.29 |
mmol/L |
||
|
TRIGLYCERIDE |
M/F |
<=18 Y |
0.40--1.29 |
mmol/L |
||
|
TRIGLYCERIDE (VLDL-CHOLESTEROL) |
M/F |
<100 Y |
<1.00 |
mmol/L |
||
|
TROPONIN I |
M/F |
<100 Y |
0.00--0.15 |
ug/L |
||
|
TSH |
M/F |
<100 Y |
0.38-5.5 |
mU/L |
||
|
UREA |
M/F |
<56 Y |
2.5--7.0 |
mmol/L |
||
|
UREA |
M/F |
56-100 Y |
2.5--9.0 |
mmol/L |
||
|
UREA CLEARANCE |
M/F |
<100 Y |
0.98--1.58 |
mL/s |
||
|
URIC ACID (URATE) |
M |
=<15 Y |
149--410 |
umol/L |
||
|
URIC ACID (URATE) |
M |
16-55 Y |
210--500 |
umol/L |
||
|
URIC ACID (URATE) |
M |
56-100 Y |
210--500 |
umol/L |
||
|
URIC ACID (URATE) |
F |
=<15 Y |
155--345 |
umol/L |
||
|
URIC ACID (URATE) |
F |
16-55 Y |
140--400 |
umol/L |
||
|
URIC ACID (URATE) |
F |
56-100 Y |
150--430 |
umol/L |
||
|
URINE AMPHETAMINE (AMPHETAMINE UR) |
M/F |
<100 Y |
Negative |
|||
|
URINE AMYLASE (AMYLASE UR) |
M/F |
<100 Y |
30--640 |
U/L |
||
|
URINE BARBITURATES (BARBITURATE UR) |
M/F |
<100 Y |
Negative |
|||
|
URINE BENZODIAZEPINE (BENZODIAZEPINE UR) |
M/F |
<100 Y |
Negative |
|||
|
URINE CALCIUM 24H (CALCIUM 24h UR) |
M/F |
<100 Y |
2.50--7.50 |
mmol/d |
||
|
URINE CATECHOLAMINES 24H (DOPAMINE 24h UR) |
M/F |
<100 Y |
400--3300 |
nmol/d |
||
|
URINE CATECHOLAMINES 24H (EPINEPHRINE 24h UR) |
M/F |
<100 Y |
0-120 |
nmol/d |
||
|
URINE CATECHOLAMINES 24H (NOREPINEPHRINE 24h UR) |
M/F |
<100 Y |
60--470 |
nmol/d |
||
|
URINE CHLORIDE (CHLORIDE UR) |
M/F |
<100 Y |
110--250 |
mmol/L |
||
|
URINE CHLORIDE 24H |
M/F |
<100 Y |
110--250 |
mmol/d |
||
|
URINE CITRATE (CITRATE UR) |
M/F |
<100 Y |
0--100 |
mmol/L |
||
|
URINE CITRATE 24H |
M/F |
<100 Y |
0.73--4.89 |
mmol/d |
||
|
URINE COCAINE (COCAINE UR) |
M/F |
<100 Y |
Negative |
|||
|
URINE COPPER 24H |
M/F |
<100 Y |
<0.6 |
umol/d |
||
|
URINE CORTISOL 24H (CORTISOL 24h UR) |
M/F |
<100 Y |
30--220 |
nmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
=<5 Y |
0.9--5.3 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
6-7 Y |
2.7--6.2 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
8-9 Y |
3.5--8.0 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
10-11 Y |
3.5--10.6 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
12-13 Y |
4.4--14.1 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
14-15 Y |
7.1--15.9 |
mmol/d |
||
|
URINE CREATININE 24H (CREATININE 24h UR) |
M/F |
16-100 Y |
7.1--17.7 |
mmol/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
0-2 D |
30--60 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
3-10 D |
100--300 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
11 D-2 M |
250--450 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
3 M-10 M |
400--500 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
11 M-2 Y |
500--600 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
3-5 Y |
600--700 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
6-8 Y |
650--1000 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
9-14 Y |
800--1400 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
15-50 Y |
600--3000 |
mL/d |
||
|
URINE CREATININE 24H (VOLUME) |
M/F |
51-100 Y |
250--3000 |
mL/d |
||
|
URINE D-PYR CROSSLINKS |
F |
<100 Y |
3.0--7.4 |
nmol/mmol Creat |
||
|
URINE D-PYR CROSSLINKS |
M |
<100 Y |
2.5--5.5 |
nmol/mmol Creat |
||
|
URINE D-PYR CROSSLINKS TIMED (URINE D-PYRIDINOLINE/CREAT) |
F |
<100 Y |
3.0--7.4 |
nmol/mmol Creat |
||
|
URINE D-PYR CROSSLINKS TIMED (URINE D-PYRIDINOLINE/CREAT) |
M |
<100 Y |
2.5--5.5 |
nmol/mmol Creat |
||
|
URINE GLUCOSE 24H (GLUCOSE 24h UR) |
M/F |
<100 Y |
0.0--1.4 |
mmol/d |
||
|
URINE HIAA 24H (HIAA 24h UR) |
M/F |
<100 Y |
0--50 |
umol/d |
||
|
URINE MACROSCOPIC (APPEARANCE) |
M/F |
<100 Y |
Clear |
|||
|
URINE MACROSCOPIC (COLOUR) |
M/F |
<100 Y |
Straw or amber |
|||
|
URINE MACROSCOPIC (GLUCOSE) |
M/F |
<100 Y |
Negative: <6 |
mmol/L |
||
|
URINE MACROSCOPIC (HEMOGLOBIN) |
M/F |
<100 Y |
Negative |
|||
|
URINE MACROSCOPIC (KETONES) |
M/F |
<100 Y |
Negative: <1.5 |
mmol/L |
||
|
URINE MACROSCOPIC (NITRITE) |
M/F |
<100 Y |
Negative |
|||
|
URINE MACROSCOPIC (pH URINE) |
M/F |
<100 Y |
5.0--8.5 |
|||
|
URINE MACROSCOPIC (PROTEIN) |
M/F |
<100 Y |
Negative: <0.3 |
g/L |
||
|
URINE MACROSCOPIC (SPECIFIC GRAVITY) |
M/F |
<100 Y |
1.003--1.035 |
|||
|
URINE MACROSCOPIC (URINE BILIRUBIN) |
M/F |
<100 Y |
Negative |
|||
|
URINE MACROSCOPIC (UROBILINOGEN) |
M/F |
<100 Y |
=<17 |
umol/L |
||
|
URINE MACROSCOPIC (WBC) |
M/F |
<100 Y |
Negative |
|||
|
URINE MAGNESIUM 24H (MAGNESIUM 24h UR) |
M/F |
<100 Y |
0.60--7.60 |
mmol/d |
||
|
URINE MERCURY 24H (URINE MERCURY) |
M/F |
<100 Y |
0--50 |
nmol/d |
||
|
URINE METANEPHRINE 24H (METANEPHRINE 24h UR) |
M/F |
<100 Y |
0.4--1.5 |
umol/d |
||
|
URINE METANEPHRINE 24H (N'METANEPH 24h UR) |
M/F |
<100 Y |
0.6--1.9 |
umol/d |
||
|
URINE METHADONE (METHADONE) |
M/F |
<100 Y |
Negative |
|||
|
URINE MICROALBUMIN 12H (ALB/CREAT 12h UR) |
M/F |
<100 Y |
0.0--1.7 |
mg/mmol Creat |
||
|
URINE MICROALBUMIN 24H (ALB/CREAT 24h UR) |
M/F |
<100 Y |
0.0--1.7 |
mg/mmol Creat |
||
|
URINE MICROALBUMIN QUANTITATIVE (ALB/CREAT UR) |
M/F |
<100 Y |
0.0--1.7 |
mg/mmol Creat |
||
|
URINE MICROALBUMIN QUANTITATIVE (ALBUMIN UR) |
M/F |
<100 Y |
<20 |
mg/L |
||
|
URINE MICROALBUMIN 24H (ALBUMIN UR) |
M/F |
<100 Y |
<20 |
mg/L |
||
|
URINE MICROALBUMIN 12H (ALBUMIN UR) |
M/F |
<100 Y |
<20 |
mg/L |
||
|
URINE MICROALBUMIN 12H (EXCRETION RATE) |
M/F |
<100 Y |
0.00--0.25 |
ug/s |
||
|
URINE MICROALBUMIN 24H (EXCRETION RATE) |
M/F |
<100 Y |
0.00--0.25 |
ug/s |
||
|
URINE MICROSCOPIC (AMORPH MATERIAL) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (CALCIUM CARBONATE) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (CALCIUM OXALATE) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (CASTS FATTY) |
M/F |
<100 Y |
0 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS GRANULAR) |
M/F |
<100 Y |
0--1 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS HYALINE) |
M/F |
<100 Y |
0--5 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS MIXED CELL) |
M/F |
<100 Y |
0 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS RBC) |
M/F |
<100 Y |
0 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS WAXY) |
M/F |
<100 Y |
0 |
/LPF |
||
|
URINE MICROSCOPIC (CASTS WBC) |
M/F |
<100 Y |
0 |
/LPF |
||
|
URINE MICROSCOPIC (MUCOUS STRANDS) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (RBC) |
M/F |
<100 Y |
<4 |
/HPF |
||
|
URINE MICROSCOPIC (SQUAMOUS EPITH) |
M/F |
<100 Y |
Normal in any number |
/HPF |
||
|
URINE MICROSCOPIC (TRIPLE PHOSPHATES) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (URATE CRYSTALS) |
M/F |
<100 Y |
Present |
/LPF |
||
|
URINE MICROSCOPIC (URINE WBC) |
M/F |
<100 Y |
<6 |
/HPF |
||
|
URINE N TELOPEPTIDE |
F |
<100 Y |
5--65 |
nmol |
||
|
URINE N TELOPEPTIDE |
M |
<100 Y |
3--51 |
nmol |
||
|
URINE OPIATES (OPIATE UR) |
M/F |
<100 Y |
Negative |
|||
|
URINE OSMOLALITY |
M/F |
<100 Y |
50--1200 |
mosmol/kg |
||
|
URINE OSMOLALITY 24H |
M/F |
<100 Y |
300--900 |
|||
|
URINE OXALATE 24H |
M/F |
=<12 Y |
140--420 |
umol/d |
||
|
URINE OXALATE 24H |
F |
12-100Y |
40--340 |
umol/d |
||
|
URINE OXALATE 24H |
M |
12-100Y |
80--490 |
umol/d |
||
|
URINE PHOSPHORUS 24H (PHOSPHATE 24h UR) |
M/F |
<100 Y |
13--42 |
mmol/d |
||
|
URINE POTASSIUM 24H (POTASSIUM 24h UR) |
M/F |
<100 Y |
25-125 |
mmol/d |
||
|
URINE POTASSIUM (URINE POTASSIUM RANDOM) |
M/F |
<100 Y |
5--100 |
mmol/L |
||
|
URINE PROTEIN (PROTEIN UR) |
M/F |
<100 Y |
<0.15 |
g/L |
||
|
URINE PROTEIN 24H (PROTEIN 24h UR) |
M/F |
<100 Y |
<0.15 |
g/d |
||
|
URINE PROTEIN ELECTROPHORESIS 24H (PROTEIN 24h UR) |
M/F |
<100 Y |
<0.15 |
g/d |
||
|
URINE SODIUM (URINE SODIUM RANDOM) |
M/F |
<100 Y |
10--150 |
mmol/L |
||
|
URINE SODIUM 24H (SODIUM 24h UR) |
M/F |
<100 Y |
40--220 |
mmol/d |
||
|
URINE UREA 24H (UREA 24h UR) |
M/F |
<100 Y |
210--710 |
mmol/d |
||
|
URINE URIC ACID 24H (URATE 24h UR) |
M |
<100 Y |
1--5 |
mmol/d |
||
|
URINE URIC ACID 24H (URATE 24h UR) |
F |
<100 Y |
1--4 |
mmol/d |
||
|
URINE VMA 24H |
M/F |
<100 Y |
7--33 |
umol/d |
||
|
UROBILINOGEN |
M/F |
<100 Y |
=<17 |
umol/L |
||
|
VALPROIC ACID |
M/F |
<100 Y |
350--700 |
umol/L |
||
|
VISCOSITY |
M/F |
<100 Y |
1.4--1.8 |
|||
|
VITAMIN B12 (B12) |
M/F |
<100 Y |
150--650 |
pmol/L |
||
|
WBC |
M/F |
=<7 D |
9.0--30.0 |
giga/L |
||
|
WBC |
M/F |
8-29 D |
5.0--20.0 |
giga/L |
||
|
WBC |
M/F |
30-59 D |
5.0--19.5 |
giga/L |
||
|
WBC |
M/F |
2-5 M |
5.5--18.0 |
giga/L |
||
|
WBC |
M/F |
6-11 M |
5.0--15.0 |
giga/L |
||
|
WBC |
M/F |
1-4 Y |
5.0--12.0 |
giga/L |
||
|
WBC |
M/F |
5-18 Y |
3.9--10.2 |
giga/L |
||
|
WBC |
M/F |
19-100 Y |
4.0--10.0 |
giga/L |
||
|
WBC DIFFERENTIAL (BASOPHILS) |
M/F |
=<7 D |
0.0--0.6 |
giga/L |
||
|
WBC DIFFERENTIAL (BASOPHILS) |
M/F |
8 D - 5 Y |
0.0--0.2 |
giga/L |
||
|
WBC DIFFERENTIAL (BASOPHILS) |
M/F |
6-18 Y |
0.0--0.1 |
giga/L |
||
|
WBC DIFFERENTIAL (BASOPHILS) |
M/F |
19-100 Y |
0.0--0.2 |
giga/L |
||
|
WBC DIFFERENTIAL (EOSINOPHILS) |
M/F |
=<7 D |
0.2--0.6 |
giga/L |
||
|
WBC DIFFERENTIAL (EOSINOPHILS) |
M/F |
8 D - 5 M |
0.2--0.8 |
giga/L |
||
|
WBC DIFFERENTIAL (EOSINOPHILS) |
M/F |
6 M-100 Y |
0.0--0.5 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
=<7 D |
2.0--10.0 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
8 D - 5 M |
2.0--17.0 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
6 M -4 Y |
3.6--12.0 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
5 Y |
2.3--8.0 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
6-11 Y |
1.5--4.2 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
12-18 Y |
1.0--3.6 |
giga/L |
||
|
WBC DIFFERENTIAL (LYMPHOCYTES) |
M/F |
19-100 Y |
1.0--3.0 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
=<5 M |
0.5--1.8 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
6-11 M |
0.0--0.9 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
1-4 Y |
0.0--0.9 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
5 Y |
0.0--0.8 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
6-18 Y |
0.0--0.7 |
giga/L |
||
|
WBC DIFFERENTIAL (MONOCYTES) |
M/F |
19-100 Y |
0.1--1.0 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
=<7 D |
2.0--20.0 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
8-29 D |
1.5--10.0 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
1-5 M |
1.5--9.5 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
6 M-4 Y |
1.5--8.5 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
5-11 Y |
1.5--8.0 |
giga/L |
||
|
WBC DIFFERENTIAL (NEUTROPHILS) |
M/F |
12-100Y |
2.0--7.5 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
=<7 D |
9.0--30.0 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
8-29 D |
5.0--20.0 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
30-59 D |
5.0--19.5 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
2-5 M |
5.5--18.0 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
6-11 M |
5.0--15.0 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
1-4 Y |
5.0--12.0 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
5-18 Y |
3.9--10.2 |
giga/L |
||
|
WBC DIFFERENTIAL (WBC) |
M/F |
19-100 Y |
4.0--10.0 |
giga/L |
||
|
ZINC |
M/F |
<100 Y |
9.2--26.0 |
umol/L |
||